EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
The company, headquartered in the key swing state of Pennsylvania, has announced the creation of 330 jobs in a significant ...
Denmark is at the forefront of integrating artificial intelligence within structured regulation, recently launching a new AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback